View
224
Download
0
Category
Preview:
Citation preview
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
1/23
Pradeep Kumar
M.pharm(pharmaceutics)
Dept. of pharmaceutics
pradeepkumar.pharma@gmail.com
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
2/23
CONTENT
Introduction
Pharmacokinetic models Pharmacodynamic models
Conclusion
References
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
3/23
Controlled release:
The term controlled release is associated with therapeutic
agents that may be automatically delivered at predetermined ratesover long period of time.
The main Goals are :
To reduce the frequency of dosing
To increase the effectiveness of the drug by localizing it
To reduce the dose requiredTo provide uniform drug delivery
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
4/23
PHARMACOKINETIC MODELS FOR CONTROLLED DRUG DELIVERY
Several models have been proposed to explain thepharmacokinetic behavior of controlled drug deliverysystems.
Models of time course profile of absorption andelimination
Loo-Riegelman and Wagner-Nelson model
Model independent pharmacokinetic analysis
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
5/23
MODELS OF TIME COURSE PROFILE OF ABSORPTION AND ELIMINATION
Based upon either zero order or first order rate constantsfor absorption and elimination.
Zero order absorption followed by first order elimination.
Slow first order absorption followed by first order elimination.
Rapid first order absorption of part of those, then release andabsorption of the reminder dose over an extended period of timeby zero order kinetic process followed by first order eliminationprocess.
Rapid first order absorption of part of those ,then release andabsorption of the reminder dose over an extended period of timeby slow first order kinetic process followed by first order eliminationprocess.
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
6/23
ASSUMPTIONS:
The elimination of the drug follows first orderprocess
The rate of distribution is governed by the rateof drug absorption
All kinetic process, except for drug absorption,are linear.
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
7/23
ZERO ORDER ABSORPTION FOLLOWED BY FIRST ORDER
ELIMINATION
Fk0C = (1 e-Ke
T)Vd ke
kO = zero order drug absorption rate constant
Zero order release systems are ideal controlled delivery
formulations.
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
8/23
First Order Absorption Followed by First Order Elimination
The concentration of the drug after single dose administrationfrom sustained release product following first order releasekinetics can be given by,
FDka
C1 = (e-ket - e-kat)Vd (ka- ke)
When ka< ke flip-flop phenomenon is observed.
Repeated dosing of first order release formulation generallyobserves, lower C max and longer TMAX in comparison toconventional release formulation
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
9/23
Rapid first order absorption of a part of dose, then release and
absorption of the reminder dose over an extended period of
time by zero order kinetic process followed by first order
elimination process
The release of the drug from dosage forms occur in two
ways :The intial dose is released for immediate availability to
be absorbed by first order process and the remaining fraction is
absorbed at constant rate i.e ., a slow zero order process which
results in zero order absorption over a prolonged period time
FDIk0 Fk0C = (e-ke
t- e
-ka
t) + (e-ket)
V(ka - ke) Vdke
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
10/23
With this model, both the rate of decline ofdrug levels from the fast release component andthe rate increase in level due to slow zero orderrelease component are controlled by drugelimination rate constant.
Cont
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
11/23
Rapid first order absorption of part of those ,thenrelease and absorption of the reminder dose over an
extended period of time by slow first order kinetic
process followed by first order elimination process This type of .formulation also contain two portions- one to describe
Rapid first order absorption and the other for slow first order
absorption.
FDIkaC= (e-ket -e-kat) +
Vd(kake)
FDMkr (e-ket -e-krt)
Vd(krke)
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
12/23
Models of time course profile of absorption and elimination
Limitations:
The absorption rate for sustained release products maybe slower the after conventional dosage form ,it may bemixed or combined first and zero order processtherefore can not be precisely described by a singlemodel dependent equation
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
13/23
Loo-Riegelman Model
This model states that the amount of drug absorbed atany given time is equal the sum of the amount of drugpresent in central comportment and peripheralcomportment and of the amount eliminated by all routes.
The only assumption with this model is the drugpharmacokinetic can be described by at least twocompartment model.
To use this model a drug must be given by the i.v. route asreference.
(XA)T/(XA) = CT+ke 0T Cdt + (XP)T/VC/ke0
T Cdt
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
14/23
Two approximations can be made from kineticequation using Loo-Riegelman model:
If a plot of percent unabsorbed [100(1-(XA)(XA)] versustime on semi logarithmic
plot yields a straight line, it is suggestiveof a apparent 1st order absorption kinetics.
If a plot of percent unabsorbed [100(1-(XA)(XA)] versustime on a rectilinear plot yield a straight line, it is
suggestive of an apparent zero order absorptionkinetics.
Cont
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
15/23
Wagner-Nelson method
Wagner-Nelson model is restricted to drugs, which follow one-compartment open-model characteristics and in a way demonstratethe actual disposition of drugs after i.v. administration.
This method has the advantage of not needing results from an i.v.reference standard.
This model is usually not recommended for the analysis of data after
oral administration of controlled delivery, which follow multi-compartmental disposition characteristics.
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
16/23
The Wagner-Nelson model is given as follows;
(XA)T/(XA)=CT + Ke 0TCdt/ Ke 0Cdt
For many drugs, which are given as SR formulations andhave a rapid distribution phase relative to drug
absorption, the Wagner- Nelson model can provide areasonable basis for the estimation of absorptionparameters.
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
17/23
Model independent pharmacokinetic analysisThe model independent disposition of the drug from a
sustained release formulation is applicable in thesituation when the drug is eliminated following linearformulation.
By using statistical moment theory, one can calculate
MRT after administration of standard and sustainedrelease formulation.
MRT is defined as the mean time for the intact drugmolecule through the body tissue and involves acomposite of all kinetic process including release fromthe dosage form drug absorption in to the body anddrug disposition.
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
18/23
The MRT can be used in comparative to evaluate the in vivoperformance of sustained release dosage form.
Longer the MRT the more sustained or prolong is the
absorption of the drug assuming a constant elimination rateconstant.
MAT is more relevant in assessing the absorption process thanMRT.
The longer the MAT the more sustained or prolonged is theabsorption of the drug.
Cont
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
19/23
MAT parameter can be used in calculation of apparentabsorption rate constant in the case of first orderabsorption process and absorption time (T) in the case of
zero order absorption process.
MAT= 1/Ka
MAT= T/2
Cont
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
20/23
Pharmacodynamic Models
Fixed effect model:
The drug concentration can be related to a pharmacological effectwhich is either observed or not.
The major draw back of fixed effect model is inability to relate a rangeof drug concentration to broad range of pharmacological effect.
Linear model:
The most fundamental model directly linking drug concentration andeffect.
E= P.C
E= P.C + EO
The parameter P estimated from E-EOversus C
E= P. log C + EO
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
21/23
Conclusion Pharmacokinetic and pharmacodynamic models help
in understanding the various parameters involved withcontrolled release systems.
They also help in designing specific requirementsrequired for drug molecules to be formulated ascontrolled release systems, there by enhancing better
opportunities for the development of controlledrelease systems in future.
7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
22/23
References
Controlled drug release, conceptsand advances,by S.P.Vyas & Roop K.Khar.
Controlled drug delivery, fundamentals &
applications,by Joseph R.Robinson, Vincent.H.L.Lee. Encyclopedia of pharmaceutical technology, by
James.Swarbrick
Applied Biopharmaceutics & pharmacokinetics,
by Leon Shargel. www.sciencedirect.com
http://www.sciencedirect.com/http://www.sciencedirect.com/7/30/2019 pharmacokinetic & pharmacodynamic (pk and pd)models of controlled release system
23/23
THANK YOU
Recommended